✦ LIBER ✦

How should lupus flares be measured? Deconstruction of the Safety of Estrogen in Lupus Erythematosus National Assessment-Systemic Lupus Erythematosus Disease Activity Index flare index

✍ Scribed by Thanou, A.; Chakravarty, E.; James, J. A.; Merrill, J. T.

Book ID: 125442933
Publisher: Oxford University Press
Year: 2014
Tongue: English
Weight: 93 KB
Volume: 53
Category: Article
ISSN: 1462-0324
DOI: 10.1093/rheumatology/keu153

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Sensitivity of the systemic lupus erythe

Sensitivity of the systemic lupus erythematosus disease activity index, British Isles lupus assessment group index, and systemic lupus activity measure in the evaluation of clinical change in childhood-onset systemic lupus erythematosus

✍ Hermine I. Brunner; Brian M. Feldman; C. Bombardier; Earl D. Silverman 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 111 KB 👁 3 views

Measures of disease activity and damage

Measures of disease activity and damage in pediatric systemic lupus erythematosus: British Isles Lupus Assessment Group (BILAG), European Consensus Lupus Activity Measurement (ECLAM), Systemic Lupus Activity Measure (SLAM), Systemic Lupus Erythematosus Disease Activity Index (SLEDAI), Physician's Global Assessment of Disease Activity (MD Global), and Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index (SLICC/ACR DI; SDI)

✍ Bianca Lattanzi; Alessandro Consolaro; Nicoletta Solari; Nicolino Ruperto; Alber 📂 Article 📅 2011 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 69 KB 👁 2 views

Assessment of disease activity and impen

Assessment of disease activity and impending flare in patients with systemic lupus erythematosus. Comparison of the use of complement split products and conventional measurements of complement

✍ Jill P. Buyon; John Tamerius; H. Michael Belmont; Steven B. Abramson 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 849 KB

## Abstract __Objective.__ To determine whether increased levels of the complement split products generated in the activation of the alternative or classical pathway accompany more severe disease activity in patients with systemic lupus erythematosus (SLE) and whether these measurements are useful